
CAS Name: Bis[(4-chlorophenyl)methylene]carbonimidic dihydrazide
Additional Names: 1,3-bis[(p-chlorobenzylidene)amino]guanidine
Percent Composition: C 53.91%, H 3.92%, Cl 21.22%, N 20.96%
Literature References: Prepn: Tomcufcik, DE 1933112 (1970 to Am. Cyanamid), C.A. 72, 90113c (1970). Activity studies: Kantor et al., Science 168, 373 (1970); Wong et al., Biochem. Biophys. Res. Commun. 46, 621 (1972). Metabolism: Zulalian et al., 163rd Am. Chem. Soc. Meeting (Boston, April 1972) Abstracts of Papers, PEST 12, 13. Animal studies: Millard, Res. Vet. Sci. 11, 394 (1970); Joyner, Norton, ibid. 13, 279 (1972).
CAS Name: 3,3-Diethyl-2,4-piperidinedione
Additional Names: 3,3-diethyl-2,4-dioxopiperidine; dihyprylone
Trademarks: Sedulon (Roche); Tusseval (Marco Viti)
Percent Composition: C 63.88%, ...
Literature References: Prepn: Tsukita, J. Pharm. Soc. Jpn. 69, 194 (1949).
CAS Name: N-[[5-Amino-2-[(4-aminophenyl)sulfonyl]phenyl]sulfonyl]acetamide monosodium salt
Additional Names: N-6-sulfanilylmetanilylacetamide N-sodium salt; N1-acetyl-6-(sulfanilylmetanilamido)...
Literature References: Prepn: Tullar, US 2358365 (1944 to Parke, Davis).
CAS Name: 3-Methoxy-16-methyl-1,3,5(10)-estratriene-16b,17b-diolTrademarks: Anvene (Searle); Manvene
Percent Composition: C 75.91%, H 8.92%, O 15.17%
Literature References: Prepn: Tyner, US 2949476 (1960 to Searle).
CAS Name: 7-(1,3-Dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione
Additional Names: 7-(1,3-dioxolan-2-ylmethyl)theophylline; 2-(7'-theophyllinemethyl)-1,3-dioxolane; doxophylli...
Literature References: Prepn: U. Avico et al., Farmaco Ed. Sci. 17, 73 (1962). Use as bronchodilator: BE 868556; J. S. Franzone, T. Tamietto, US 4187308 (1978, 1980 to Istituto Biologico Chemioterapico ABC). Pharmacology: J. S. Franzone et al., Farmaco Ed. Sci. 36, 201 (1981). Pharmacodynamics and toxicity in rats: J. S. Franzone et al., ibid. 220. HPLC determn in pharmaceutical compositions: C. Badini et al., Farmaco Ed. Prat. 37, 320 (1982). Clinical trial in obstructive pneumopathy: C. Bucca et al., Int. J. Clin. Pharmacol. Res. 11, Suppl 1, 101 (1982).
Percent Composition: Fe 22.27%, H 2.41%, O 38.27%, P 37.05%
Literature References: Prepn: U.S.D. 25th ed, p 573.
CAS Name: 4-[(5-Chloro-2-oxo-3(2H)-benzothiazolyl)acetyl]-1-piperazineethanol
Additional Names: 5-chloro-3-[4-(2-hydroxyethyl)-1-piperazinyl]carbonylmethyl-2-benzothiazolinone; tialamide
Per...
Literature References: Prepn: Umio et al., JP 71 15302 C.A. 75, 36127j (1971); eidem, JP 71 18752 C.A. 75, 63824r (1971); Umio, US 3661921 (1971, 1971, 1972 all to Fujisawa). Pharmacology: Takashima et al., Arzneim.-Forsch. 22, 711 (1972); Tsurumi et al., ibid. 716, 724. Metabolism: Noda et al., ibid. 732. Toxicity studies: Watanabe et al., ibid. 23, 504 (1973). Mode of antiasthmatic action: G. C. Folco et al., Pharmacol. Res. Commun. 11, 703 (1979).
CAS Name: 2-[3-(5-Nitro-2-furanyl)-1-[2-(5-nitro-2-furanyl)ethenyl]-2-propenylidene]hydrazinecarboximidamide
Additional Names: [[3-(5-nitro-2-furyl)-1-[2-(5-nitro-2-furyl)vinyl]allylidene]amino...
Literature References: Prepn: Uota et al., JP 52 2673 (1952 to Toyama), C.A. 48, 2115h (1954); Uoda, Tanizaki, JP 64 4479 (1964 to Fukuju Pharm.), C.A. 62, 10412f (1965).
CAS Name: Hexakis[m-(acetato-kO:kO')]-m4-oxotetraberyllium
Additional Names: beryllium oxide acetate
Percent Composition: C 35.47%, H 4.47%, Be 8.87%, O 51.19%
Literature References: Prepn: Urbain, Lacombe, Compt. Rend. 133, 874 (1901); 134, 772 (1902); Haber, van Oordt, Z. Anorg. Chem. 40, 465 (1904); Moeller et al., Inorg. Synth. 3, 9 (1950).
CAS Name: 5-Methylpyrazinecarboxylic acid 4-oxide
Additional Names: 2-carboxy-5-methylpyrazine 4-oxideTrademarks: Olbemox (Pharmacia); Olbetam (Pharmacia)
Percent Composition: C 46.76%, H 3....
Literature References: Prepn: V. Ambrogi et al., DE 2319834; eidem, US 4002750 (1973, 1977 both to Carlo Erba). Prepn and toxicology: eidem, Eur. J. Med. Chem. 15, 157 (1980). Pharmacological profile: P. P. Lovisolo et al., Pharmacol. Res. Commun. 13, 151, 163 (1981). Pharmacokinetics: L. M. Fuccella et al., Clin. Pharmacol. Ther. 28, 790 (1980); L. Musatti et al., J. Int. Med. Res. 9, 381 (1981). Mechanism of action: K. Aktories et al., Arzneim.-Forsch. 33, 1525 (1983).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
